![USANA Health Sciences](/common/images/company/NY_USNA.png)
USANA Health Sciences (USNA)
NYSE
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 233.3M | 227.96M | 248.36M | 238.2M | 213.37M | 221.08M | 227.8M | 212.87M |
Operating Income | 22.63M | 22.55M | 26.85M | 24.4M | 17.61M | 24.22M | 24.67M | 17.84M |
Pre Tax Income | 23.22M | 22.8M | 28.5M | 26.81M | 20.53M | 26.61M | 27.11M | 20.2M |
Net Income | 14.93M | 12.8M | 18.38M | 17.29M | 11.35M | 16.77M | 16.54M | 10.43M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 22.34M | 21.38M | 26.76M | 24.54M | 17.84M | 23.85M | 24.49M | 17.49M |
EBITDA | 26.1M | 33.54M | 30.14M | 27.62M | 20.88M | 27.17M | 27.83M | 21.65M |
Year End December 29 2023 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.01B | 1.05B | 1.19B | 1.06B | 1.13B | 1.19B | 998.6M | 921.01M |
Operating Income | 138.62M | 132.5M | 188.35M | 146.19M | 176.49M | 170.19M | 107.61M | 93.07M |
Pre Tax Income | 138.55M | 134.64M | 191.51M | 150.5M | 177.95M | 170.64M | 108.62M | 102.45M |
Net Income | 100.04M | 62.54M | 126.22M | 100.53M | 124.66M | 116.51M | 69.35M | 63.79M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 4.086 | 2.603 | 5.356 | 4.642 | 5.926 | 6.008 | 3.612 | 3.334 |
EBIT | 137.52M | 132.5M | 187.12M | 145.86M | 175.92M | 168.18M | 105.02M | 93.08M |
EBITDA | 152M | 148.46M | 205.08M | 168.98M | 198.82M | 192.19M | 128.71M | 105.81M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.